News
Brawn Biotech standalone net profit declines 57.14% in the September 2026 quarter
05-Nov-2026 | 16:22
Sales rise 14.93% to Rs 5.62 crore
Net profit of Brawn Biotech declined 57.14% to Rs 0.03 crore in the quarter ended September 2026 as against Rs 0.07 crore during the previous quarter ended September 2025. Sales rose 14.93% to Rs 5.62 crore in the quarter ended September 2026 as against Rs 4.89 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 5.62 | 4.89 | 15 |
| OPM % | -1.42 | 0.20 | - |
| PBDT | 0.06 | 0.10 | -40 |
| PBT | 0.03 | 0.07 | -57 |
| NP | 0.03 | 0.07 | -57 |
Powered by Capital Market - Live News